A new panel of blood biomarkers for the diagnosis of mild traumatic brain injury/concussion in adults

Journal of Neurotrauma

Volumn 33, Issue 1, 2016, Pages 49-57

  Shan, Rongzi ^a   Szmydynger Chodobska, Joanna ^a   Warren, Otis U ^a   Mohammad, Farah ^b   Zink, Brian J ^a   Chodobski, Adam ^a  

^a BROWN UNIVERSITY   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

blood biomarkers; concussion; diagnosis; mild traumatic brain injury

Indexed keywords

BIOLOGICAL MARKER; COPEPTIN; CXCL1 CHEMOKINE; GALECTIN 3; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; OCCLUDIN; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; GLYCOPEPTIDE; MMP9 PROTEIN, HUMAN; OCLN PROTEIN, HUMAN;

ACCIDENT; ADULT; ARTICLE; BLOOD SAMPLING; BONE INJURY; BRAIN CONCUSSION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC INJURY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; TRAUMATIC BRAIN INJURY; BLOOD; MIDDLE AGED;

ADULT; BIOMARKERS; BRAIN CONCUSSION; FEMALE; GALECTIN 3; GLYCOPEPTIDES; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; OCCLUDIN;

EID: 84952896360     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2014.3811     Document Type: Article

References (32)

1. Faul M, Xu L, Wald M.M, and Coronado V. (2010). Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths, 2002-2006. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control: Atlanta, GA.
2. Tagliaferri F, Compagnone C, Korsic M, Servadei F, and Kraus J. (2006). A systematic review of brain injury epidemiology in Europe. Acta Neurochir. (Wien) 148, 255-268.
3. Cassidy J.D, Carroll L.J, Peloso P.M, Borg J, von Holst H, Holm L, Kraus J, and Coronado V.G. (2004). Incidence, risk factors and prevention of mild traumatic brain injury: results of the WHO Collaborating Centre Task Force on Mild Traumatic Brain Injury. J. Rehabil. Med. Suppl. 43, 28-60.
4. Williamson I.J, and Goodman D. (2006). Converging evidence for the under-reporting of concussions in youth ice hockey. Br. J. Sports Med. 40, 128-132.
5. Rigg J.L, and Mooney S.R. (2011). Concussions and the military: issues specific to service members. Pm R 3, Suppl. 2, S380-S386.
6. Mondello S, Schmid K, Berger R.P, Kobeissy F, Italiano D, Jeromin A, Hayes R.L, Tortella F.C, and Buki A. (2014). The challenge of mild traumatic brain injury: role of biochemical markers in diagnosis of brain damage. Med. Res. Rev. 34, 503-531.
7. Papa L, Lewis L.M, Falk J.L, Zhang Z, Silvestri S, Giordano P, Brophy G.M, Demery J.A, Dixit N.K, Ferguson I, Liu M.C, Mo J, Akinyi L, Schmid K, Mondello S, Robertson C.S, Tortella F.C, Hayes R.L, and Wang K.K. (2012). Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann. Emerg. Med. 59, 471-483.
8. Papa L, Lewis L.M, Silvestri S, Falk J.L, Giordano P, Brophy G.M, Demery J.A, Liu M.C, Mo J, Akinyi L, Mondello S, Schmid K, Robertson C.S, Tortella F.C, Hayes R.L, and Wang K.K. (2012). Serum levels of ubiquitin C-Terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J. Trauma Acute Care Surg. 72, 1335-1344.
9. Siman R, Giovannone N, Hanten G, Wilde E.A, McCauley S.R, Hunter J.V, Li X, Levin H.S, and Smith D.H. (2013). Evidence that the blood biomarker SNTF predicts brain imaging changes and persistent cognitive dysfunction in mild TBI patients. Front. Neurol. 4, 190.
10. Siman R, Shahim P, Tegner Y, Blennow K, Zetterberg H, and Smith D.H. (2015). Serum SNTF increases in concussed professional ice hockey players and relates to the severity of post-concussion symptoms. J. Neurotrauma May 14. doi: 10.1089/neu.2014.3698. [Epub ahead of print
11. Shahim P, Tegner Y, Wilson D.H, Randall J, Skillback T, Pazooki D, Kallberg B, Blennow K, and Zetterberg H. (2014). Blood biomarkers for brain injury in concussed professional ice hockey players. JAMA Neurol. 71, 684-692.
12. Shahim P, Linemann T, Inekci D, Karsdal M.A, Blennow K, Tegner Y, Zetterberg H, and Henriksen K. (2015). Serum tau fragments predict return to play in concussed professional ice hockey players. J. Neurotrauma doi: 10.1089/neu.2014.3741. (in press
13. Gatson J.W, Barillas J, Hynan L.S, Diaz-Arrastia R, Wolf S.E, and Minei J.P. (2014). Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury. J. Neurosurg. 121, 1232-1238.
14. Perez-Polo J.R, Rea H.C, Johnson K.M, Parsley M.A, Unabia G.C, Xu G, Infante S.K, Dewitt D.S, and Hulsebosch C.E. (2013). Inflammatory consequences in a rodent model of mild traumatic brain injury. J. Neurotrauma. 30, 727-740.
15. Redell J.B, Moore A.N, Grill R.J, Johnson D, Zhao J, Liu Y, and Dash P.K. (2013). Analysis of functional pathways altered after mild traumatic brain injury. J. Neurotrauma. 30, 752-764.
16. Natale J.E, Ahmed F, Cernak I, Stoica B, and Faden A.I. (2003). Gene expression profile changes are commonly modulated across models and species after traumatic brain injury. J. Neurotrauma. 20, 907-927.
17. Chodobski A, Zink B.J, and Szmydynger-Chodobska J. (2014). CNS barriers in neurotrauma, in: Vascular Mechanisms in CNS Trauma. E.H. Lo J. Lok M.M. Ning, and M.J. Whalen (eds). Springer: New York, pps. 3-28.
18. McCrory P, Meeuwisse W.H, Aubry M, Cantu B, Dvorak J, Echemendia R.J, Engebretsen L, Johnston K, Kutcher J. S, Raftery M, Sills A, Benson B.W, Davis G.A, Ellenbogen R.G, Guskiewicz K, Herring S.A, Iverson G.L, Jordan B.D, Kissick J, McCrea M, McIntosh A.S, Maddocks D, Makdissi M, Purcell L, Putukian M, Schneider K, Tator C.H, and Turner M. (2013). Consensus statement on concussion in sport: The 4th International Conference on Concussion in Sport held in Zurich, November 2012. Br. J. Sports. Med. 47, 250-258.
19. Manley G.T, Diaz-Arrastia R, Brophy M, Engel D, Goodman C, Gwinn K, Veenstra T.D, Ling G, Ottens A.K, Tortella F, and Hayes R.L. (2010). Common data elements for traumatic brain injury: recommendations from the Biospecimens and Biomarkers Working Group. Arch. Phys. Med. Rehabil. 91, 1667-1672.
20. Liu W, Hendren J, Qin X.J, Shen J, and Liu K.J. (2009). Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. J. Neurochem. 108, 811-820.
21. Szmydynger-Chodobska J, Fox L.M, Lynch K.M, Zink B.J, and Chodobski A. (2010). Vasopressin amplifies the production of proinflammatory mediators in traumatic brain injury. J. Neurotrauma. 27, 1449-1461.
22. Szmydynger-Chodobska J, Zink B.J, and Chodobski A. (2011). Multiple sites of vasopressin synthesis in the injured brain. J. Cereb. Blood Flow Metab. 31, 47-51.
23. Struck J, Morgenthaler N.G, and Bergmann A. (2005). Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides. 26, 2500-2504.
24. Bazarian J.J, Blyth B.J, He H, Mookerjee S, Jones C, Kiechle K, Moynihan R, Wojcik S.M, Grant W.D, Secreti L.M, Triner W, Moscati R, Leinhart A, Ellis G.L, and Khan J. (2013). Classification accuracy of serum Apo A-I and S100B for the diagnosis of mild traumatic brain injury and prediction of abnormal initial head computed tomography scan. J. Neurotrauma. 30, 1747-1754.
25. Nygren De Boussard C, Fredman P, Lundin A, Andersson K, Edman G, and Borg J. (2004). S100 in mild traumatic brain injury. Brain Inj. 18, 671-683.
26. Terrando N, Eriksson L.I, Ryu J.K, Yang T, Monaco C, Feldmann M, Jonsson Fagerlund M, Charo I.F, Akassoglou K, and Maze M. (2011). Resolving postoperative neuroinflammation and cognitive decline. Ann. Neurol. 70, 986-995.
27. Dong X.Q, Huang M, Yang S.B, Yu W.H, and Zhang Z.Y. (2011). Copeptin is associated with mortality in patients with traumatic brain injury. J. Trauma. 71, 1194-1198.
28. Roberts D.J, Jenne C.N, Leger C, Kramer A.H, Gallagher C.N, Todd S, Parney I.F, Doig C.J, Yong V.W, Kubes P, and Zygun D.A. (2013). A prospective evaluation of the temporal matrix metalloproteinase response after severe traumatic brain injury in humans. J. Neurotrauma. 30, 1717-1726.
29. Hadass O, Tomlinson B.N, Gooyit M, Chen S, Purdy J.J, Walker J.M, Zhang C, Giritharan A.B, Purnell W, Robinson C.R. 2nd, Shin D, Schroeder V.A, Suckow M.A, Simonyi A, Sun G.Y, Mobashery S, Cui J, Chang M, and Gu Z. (2013). Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury. PLoS One 8, e76904.
30. Zetterberg H, Hietala M.A, Jonsson M, Andreasen N, Styrud E, Karlsson I, Edman A, Popa C, Rasulzada A, Wahlund L.O, Mehta P.D, Rosengren L, Blennow K, and Wallin A. (2006). Neurochemical aftermath of amateur boxing. Arch. Neurol. 63, 1277-1280.
31. Venkatesan C, Chrzaszcz M, Choi N, and Wainwright M.S. (2010). Chronic upregulation of activated microglia immunoreactive for galectin-3/Mac-2 and nerve growth factor following diffuse axonal injury. J. Neuroinflammation. 7, 32.
32. Lin C.C, Wang J.H, Wu H.W, and Lee G.B. (2010). Microfluidic immunoassays. J. Assoc. Lab. Automat. 15, 253-274.